IndiCell's goal is to establish and consolidate a sustainable, collaborative, world-leading innovation milieu based on Individual cell therapy. IndiCell will develop state-of-the-art processes utilizing our own world-leading projects as examples. These procedures and IndiCell's expertise will reduce costs, labor, time, and regulatory hurdles for future iPSC treatment studies in Sweden, reducing the innovation barrier.
Three main aims of IndiCell:
- Develop iPS cell-based therapy for two model project, Parkinson’s disease and Macular degeneration
- Create a development pipeline for iPS cell therapies that includes state-of-the-art workflows addressing generic processes, competence, and quality controls
- Become an important global actor within stem cell therapies